Compare RYAAY & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAAY | MDLN |
|---|---|---|
| Founded | 1985 | 1966 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5B | 30.7B |
| IPO Year | 2003 | 2025 |
| Metric | RYAAY | MDLN |
|---|---|---|
| Price | $52.61 | $35.14 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 27 |
| Target Price | ★ $67.52 | $44.42 |
| AVG Volume (30 Days) | 1.7M | ★ 7.6M |
| Earning Date | 11-02-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.23 |
| Revenue | N/A | ★ $28,432,000,000.00 |
| Revenue This Year | $2.33 | $9.84 |
| Revenue Next Year | $9.29 | $7.85 |
| P/E Ratio | ★ $12.60 | $156.39 |
| Revenue Growth | N/A | ★ 11.47 |
| 52 Week Low | $51.02 | $31.49 |
| 52 Week High | $74.24 | $50.88 |
| Indicator | RYAAY | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 42.96 | 50.76 |
| Support Level | $51.68 | $35.07 |
| Resistance Level | $56.12 | $37.22 |
| Average True Range (ATR) | 1.06 | 0.97 |
| MACD | -0.19 | 0.07 |
| Stochastic Oscillator | 33.07 | 42.62 |
Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 daily flights across more than 220 airports in 36 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.